| SC 13G/A | 2015-02-17 | Aspire Capital Fund, LLC | APRICUS BIOSCIENCES, INC. | 2,267,000 | 5.1% | EDGAR |
| SC 13G/A | 2015-02-17 | Aspire Capital Fund, LLC | APRICUS BIOSCIENCES, INC. | 2,267,000 | 4.5% | EDGAR |
| SC 13G | 2015-01-05 | Forendo Pharma Oy | APRICUS BIOSCIENCES, INC. | 3,420,066 | 7.8% | EDGAR |
| SC 13G | 2014-11-20 | Aspire Capital Fund, LLC | APRICUS BIOSCIENCES, INC. | 2,296,500 | 5.3% | EDGAR |
| SC 13G/A | 2011-02-14 | TAIL WIND FUND LTD | APRICUS BIOSCIENCES, INC. | 544,000 | - | EDGAR |
| SC 13G | 2010-04-01 | TAIL WIND FUND LTD | NEXMED INC | 5,862,069 | 5.2% | EDGAR |
| SC 13D/A | 2008-12-23 | LOEB PARTNERS CORP | NEXMED INC | - | 0.0% | EDGAR |
| SC 13G/A | 2008-12-23 | Southpoint Capital Advisors LP | NEXMED INC | 4,261,715 | 4.8% | EDGAR |
| SC 13D/A | 2008-09-12 | LOEB PARTNERS CORP | NEXMED INC | - | 0.3% | EDGAR |
| SC 13G/A | 2008-09-11 | Southpoint Capital Advisors LP | NEXMED INC | 7,927,952 | 9.0% | EDGAR |
| SC 13G/A | 2008-09-10 | FMR LLC | NEXMED INC | 2,720,912 | 3.2% | EDGAR |
| SC 13G/A | 2008-02-14 | FMR LLC | NEXMED INC | 12,427,739 | 15.0% | EDGAR |
| SC 13G/A | 2008-02-14 | RA CAPITAL MANAGEMENT, LLC | NEXMED INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2007-04-27 | Southpoint Capital Advisors LP | NEXMED INC | 14,041,002 | 17.5% | EDGAR |
| SC 13G | 2007-03-12 | FMR CORP | NEXMED INC | 6,751,406 | 10.1% | EDGAR |
| SC 13G/A | 2007-01-05 | Southpoint Capital Advisors LP | NEXMED INC | 11,377,102 | 14.2% | EDGAR |
| SC 13G | 2007-01-03 | RA CAPITAL MANAGEMENT, LLC | NEXMED INC | 6,658,500 | 8.3% | EDGAR |
| SC 13D/A | 2006-12-14 | LOEB PARTNERS CORP | NEXMED INC | 131,418 | 0.2% | EDGAR |
| SC 13G | 2006-10-17 | Southpoint Capital Advisors LP | NEXMED INC | 3,370,787 | 5.1% | EDGAR |
| SC 13D | 2006-03-07 | LOEB PARTNERS CORP | NEXMED INC | 413,297 | 0.6% | EDGAR |